Life Sciences Conferences

The Indiana Life Sciences Forum

Sponsor Statements

---

PRESENTED BY:

Burrill & Company

One Embarcadero Center
Suite 2700
San Francisco, CA  94111
(415) 591-5400
www.burrillandco.com

COMPANY STATEMENT:

Burrill & Company is a San Francisco-based global leader in life sciences with principal activities in
Venture Capital/Private Equity, Merchant Banking and Media. The company’s over 60-person scientific and business team, supported by its Advisory Boards, the strategic and financial network of its limited partners, and the close relationships developed with numerous life science companies and management www.burrillandco.com teams, provide Burrill with unparalleled access and insight. Burrill’s Media Group organizes over a dozen life sciences conferences and events, and publishes The Annual Biotech Books, The Journal of Life Sciences and numerous Burrill BioIntelligence Reports.

---

PRESENTED BY:

BioCrossroads

BioCrossroads
300 N. Meridian St. Suite 950
Indianapolis, IN 46204
(317) 238-2450
www.biocrossroads.com

COMPANY STATEMENT:

BioCrossroads is Indiana's comprehensive initiative to grow the life sciences, a public-private collaboration that supports the region's research and corporate strengths while encouraging new business development.  BioCrossroads provides money and support to life sciences businesses, promotes strategic collaborations among Indiana's research universities, launches new life sciences
enterprises (Indiana Health Information Exchange, Fairbanks Institute for Healthy Communities, BioCrossroadsLINX, and Datalys Center) expands partnerships among Indiana's life science research, business and community institutions, promotes science education and markets the
diverse capabilities of Indiana's life sciences sector.

---

GOLD SPONSOR

Aptuit

Two Greenwich Office Park
Greenwich, CT 06831
(203) 422-6600
www.aptuit.com

COMPANY STATEMENT:

Aptuit is a drug development and pharmaceutical services company conducting research, development and manufacturing on a global contract basis for both large and small innovators. Our mission is to engineer a better drug development process to provide solutions to our clients’ diverse and differing program needs.

---

GOLD SPONSOR

Baker & Daniels

COMPANY STATEMENT:

 

---

GOLD SPONSOR

Cook

COMPANY STATEMENT:

---

GOLD SPONSOR

Lily

COMPANY STATEMENT:

---

SILVER SPONSOR

Credit Suisse

COMPANY STATEMENT:

---

SILVER SPONSOR

Indiana University107 South Indiana Avenue
Bloomington, IN 47405-7000
United States
(317) 231-2114
www.innovate.indiana.edu

COMPANY STATEMENT:

Indiana University is internationally known for the quality of our academic programs, which attract students from all over the world. At the same time, we aggressively recruit Hoosiers for a first-rate, affordable education. Since 2007, IU climbed 21 places and now ranks 34th among the 500 public U.S. colleges that were reviewed for the Kiplinger’s list of the “100 Best Values in Public Colleges.”

More than 250,000 IU graduates live in Indiana, and we prepared them for great jobs. In fact, IU is the major producer of professionals for 9 of the top 10 “Hoosier Hot Jobs,” as established by the Indiana Department of Workforce Development. With eight campuses and nine medical education centers around the state, we educate more of the state’s nurses, teachers, dentists, IT professionals, surgeons, lawyers, and police officers than any other Indiana college or university. And, we’re committed to recruiting Indiana’s best and brightest and preparing them for the great jobs here at home.

We also harness the resources of IU to assist Indiana in the global economy, building on our strengths in research to keep—and attract—top talent.  IU represents the single largest repository of international expertise in the state, and our faculty are conducting world-class research on critical issues of the 21st century and transferring their discoveries to the marketplace as never before. In fact, we have consistently brought in more sponsored research dollars than all of Indiana’s public and private research universities combined. In 2008, we were awarded over $525 million in external research funding—a 21 percent increase over the previous year.
Earlier this year, leaders of Indiana University and Purdue University announced the creation of the Indiana Clinical and Translational Sciences Institute, a medical research initiative that will combine the strengths of the universities, business and government to swiftly transform discoveries into better patient care and business opportunities.

IU and Purdue are also joining forces to grow Indiana’s economy with the Indiana Innovation Alliance.  This unprecedented union connects the efforts of academia, business, and government to amplify Indiana’s assets in biosciences and life sciences. Together, we’ll do more for Hoosiers: more jobs, more companies, more cures, and better healthcare.

Finally, IU provides ideal conditions for cultivating entrepreneurs. Our top-ranked entrepreneurship programs and flourishing business incubators yield startups in high-growth fields, and new jobs are cropping up around the state. Furthermore, Indiana’s business community can tap into the Johnson Center for Entrepreneurship and Innovation, the IU Emerging Technologies Center, the IU Research & Technology Corporation, the Kelley School of Business Center for the Business of Life Sciences, and the Indiana Life and Health Sciences Initiative for help with business formation, strategic planning, and acquisition of venture capital. Education may be our business, but ideas are our passion.  

 

---

 

 

BRONZE SPONSOR

CAI

COMPANY STATEMENT:

---

BRONZE SPONSOR

Deloitte

Chase Tower
111 Monument Circle
Suite 2000
Indianapolis, Indiana 46204-5108
(317) 464-8600
www.deloitte.com

COMPANY STATEMENT:

The multidisciplinary strengths of our Life Sciences practice offer the resources necessary to address the wide range of issues affecting business growth for established as well as early stage and emerging life sciences companies. From inception and incorporation, to an initial public offering or a new global product launch, our professionals have the comprehensive experience that life sciences companies demand to address the assurance, tax and consulting needs of their expanding business. Working together, we align your team with the proper resources to meet these unique needs.

We work with our clients on many issues, including:
• Audit and Assurance
• Strategic Alliances and Collaborations
• Corporate Governance, Internal Control and Sarbanes Accountability
• FDA, Regulatory, Clinical Trials, and OIG Compliance
• Rebate and Pricing Strategy and Compliance
• Royalty and Revenue Recovery
• Capital Markets Access and Venture Capital
• Intellectual Property Protection
• Merger Integration and Acquisition Services
• Company and Product Launch Capabilities
• Tax Jurisdictional Strategies & Compliance
• Human Resource Issues
• Security and Control of Products
• Technology Solutions and Implementation

Working with Industry Leaders
Our National Life Sciences & Health Care Practice is proud to serve:
• Nearly 85% of Fortune 1,000 Health Care & Life Sciences companies
• 10 of the 10 largest pharmaceutical manufacturers (as ranked by Hoover’s Inc.)
• 10 of the 10 largest medical equipment manufacturers (as ranked by Hoover’s Inc.)
• 10 of the 10 largest biotechnology companies (as ranked by Hoover’s Inc.)

Best in Class Professionals
Our people drive our success in serving life sciences organizations. They are deeply committed to this industry — having spent time as clinicians, research specialists, regulatory and compliance professionals, forensic investigators, lawyers, accountants, financial analysts, information technology directors, statisticians, billers, coders, and senior industry executives — and enjoy their reputation as excellent client service practitioners.
Because of this, every aspect of our professional commitment and responsiveness reflects a dedication of substantial resources to provide our professionals with what they need to better serve our clients.

 

---

 

BRONZE SPONSOR

IEDC

Indiana Economic Development Corporation
Nathan J. Feltman, Secretary of Commerce
One North Capitol, Suite 700
Indianapolis, IN 46204
Tel: 317.232.8800
Fax: 317.232.4146
www.AccelerateIndiana.com
iedc@iedc.in.gov

COMPANY STATEMENT:

Intellectual capital, public support, academic partnerships, workforce excellence, and business and industry collaborations are the driving force behind Indiana’s life sciences industry.

Indiana has been a center of innovations in the life sciences, pharmaceutical and medical device industries for more than a century and today boasts the second highest concentration of biopharmaceutical jobs in the nation and the fifth largest pharmaceutical industry in the country.

Pharmaceutical and medical device industry leaders like Eli Lilly and Company, Zimmer, Biomet, and DePuy Orthopedics are based in Indiana. The state is also home to WellPoint, a health insurance underwriter; Roche Diagnostics, the top medical diagnostics company in the world; and the Regenstrief Institute, which is the world’s largest database of electronic medical records.

The Indiana Economic Development Corporation (IEDC), the state of Indiana’s lead economic development agency, builds on this foundation to help life sciences companies from across the nation and around the globe find the talent and resources they need to build success.

The IEDC aggressively seeks out job-creating investments in all industries. However, the state places special emphasis on life sciences, advanced manufacturing, motorsports, transportation, distribution and logistics, and information technology.

Located in the heart of the Midwest, Indiana offers a low-cost, pro-business environment – including low utility costs, workers’ compensation and unemployment insurance rates – coupled with a highly skilled, educated and capable workforce.

Indiana is one of the most affordable places to do business in both the Midwest and the nation, according to Forbes magazine. The Tax Foundation notes that Indiana has the lowest overall tax burden in the Midwest and 12th lowest nationally. Chief Executive magazine ranked Indiana as first in the Midwest and eighth in the nation as a “Best State to Do Business.”

Financial broadcaster CNBC this year ranked Indiana as the “most improved” state in the United States for business. And, for the first time in the state’s history, Indiana’s credit rating has been raised to AAA, the highest rating assigned by the independent credit rating agency Standard & Poor’s Ratings Service (S&P).

The IEDC’s efforts to attract and foster economic growth in the life sciences are supported by the state’s pro-business environment, which enables participants to benefit from strong ties between universities and research facilities, thriving public-private collaborations, business expertise, venture capital funding, and supportive government policies.

In short, Indiana offers the environment, opportunity, encouragement and funding support needed for life sciences success.

 

---

 

BRONZE SPONSOR

PAPPAS VENTURES

P.O. Box 110287
Research Triangle Park, NC  27709
919-998-3300
919-998-3301 (fax)
www.pappasventures.com/
info@pappasventures.com

COMPANY STATEMENT:

Pappas Ventures is a Research Triangle Park, North Carolina-based venture capital firm that invests nationally in the life science industry. Founded in 1994, Pappas has over $250 million under management, and is currently investing out of its third venture capital fund. Among the firm’s more than 40 portfolio companies are Arena Pharmaceuticals (Nasdaq: ARNA), NuVasive (Nasdaq: NUVA), Panacos (Nasdaq: PANC), Peninsula Pharmaceuticals (acquired by Johnson & Johnson), Cerexa (acquired by Forest Laboratories), Syntonix Pharmaceuticals (acquired by Biogen Idec), and CoLucid Pharmaceuticals. The firm's primary investment focus is on product-oriented biotechnology and pharmaceutical companies, with a secondary focus on medical technologies.

---

EVENTS PARTNERS

BioCentury

COMPANY STATEMENT:

---

EVENTS PARTNERS

KentuckyBio Alliance

COMPANY STATEMENT:

 

---

EVENTS PARTNERS

Pharmalicensing

COMPANY STATEMENT: